Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATTRACTION-4: Opdivo in advanced gastric cancer
NCT02746796Phase 3Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Mar 2016
- Primary completion
- Jan 2020
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 3 trial of nivolumab in gastric cancer (GC), gastroesophageal junction cancer, sponsored by Ono Pharmaceutical. Started Mar 2016; status: completed.
02
Drugs
03
Conditions
gastric cancer (GC)gastroesophageal junction cancer
Beyond the preview
Go deeper on NCT02746796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02746796.